sec filing
CC
NASDAQ · CCCC
C4 Therapeutics, Inc.
Healthcare · Biotechnology
$4.10
Down-$0.25 (-6.10%)
Updated Aug 28, 2026, 8:54 PM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 180.43M
- P/E ratio
- -1.54
- Dividend yield
- 0.00%
- 52-week range
- $2.30 – $5.17
- Volume
- 1.99M
- Avg. volume
- 2.1M
Price performance
CCCC price history
1M range · 21 trading sessions · Daily adjusted prices
CCCC closed at $4.10 after 21 trading sessions, up 12.02% for the selected period.
- Last close
- $4.10
- Period change
- +12.02%
- Period low
- $3.48
- Period high
- $4.27
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $4.25 | $4.30 | $4.09 | $4.10 | 1.99M |
| Aug 26, 2026 | $4.17 | $4.24 | $4.03 | $4.24 | 1.86M |
| Aug 25, 2026 | $4.11 | $4.235 | $4.085 | $4.20 | 4.29M |
| Aug 24, 2026 | $3.97 | $4.14 | $3.81 | $4.10 | 1.75M |
| Aug 21, 2026 | $4.07 | $4.10 | $3.935 | $4.00 | 1.16M |
| Aug 20, 2026 | $4.14 | $4.15 | $3.832 | $4.03 | 2.27M |
| Aug 19, 2026 | $4.25 | $4.375 | $4.13 | $4.21 | 2.85M |
| Aug 18, 2026 | $4.21 | $4.30 | $4.105 | $4.18 | 2.88M |
| Aug 17, 2026 | $4.315 | $4.315 | $4.108 | $4.265 | 2.09M |
| Aug 14, 2026 | $4.07 | $4.315 | $3.895 | $4.24 | 3.4M |
| Aug 13, 2026 | $3.93 | $4.23 | $3.86 | $4.08 | 3.73M |
| Aug 12, 2026 | $3.95 | $3.995 | $3.8251 | $3.90 | 1.96M |
| Aug 11, 2026 | $3.84 | $4.00 | $3.64 | $3.87 | 3.09M |
| Aug 10, 2026 | $3.75 | $3.75 | $3.60 | $3.62 | 1.96M |
| Aug 7, 2026 | $3.69 | $3.7497 | $3.65 | $3.73 | 1.5M |
| Aug 6, 2026 | $3.62 | $3.72 | $3.58 | $3.64 | 1.82M |
| Aug 5, 2026 | $3.61 | $3.68 | $3.54 | $3.62 | 2.56M |
| Aug 4, 2026 | $3.57 | $3.6385 | $3.47 | $3.61 | 2.52M |
| Aug 3, 2026 | $3.50 | $3.535 | $3.36 | $3.50 | 2.24M |
| Jul 31, 2026 | $3.66 | $3.66 | $3.45 | $3.48 | 1.95M |
| Jul 30, 2026 | $3.53 | $3.69 | $3.515 | $3.66 | 3.15M |
Latest CCCC news
The latest Smart Investors Daily articles mentioning CCCC.
Stock researchResearch & News · Competitors
Loading stock research…

